A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2
Gespeichert in:
| Weitere Verfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2009
|
| In: |
BMC cancer
Year: 2009, Jahrgang: 9 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-9-160 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-9-160 Verlag, Volltext: http://www.biomedcentral.com/1471-2407/9/160 
|
| Verfasserangaben: | Angela Märten, Jan Schmidt, Jennifer Ose, Sabine Harig, Ulrich Abel, Marc W Münter, Dirk Jäger, Helmut Friess, Julia Mayerle, Guido Adler, Thomas Seufferlein, Thomas Gress, Roland Schmid and Markus W Büchler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 622631748 | ||
| 003 | DE-627 | ||
| 005 | 20220810013401.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 100325s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-9-160 |2 doi | |
| 035 | |a (DE-627)622631748 | ||
| 035 | |a (DE-576)9622631746 | ||
| 035 | |a (DE-599)GBV622631748 | ||
| 035 | |a (OCoLC)1340137312 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 2 | |a A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2 |c Angela Märten, Jan Schmidt, Jennifer Ose, Sabine Harig, Ulrich Abel, Marc W Münter, Dirk Jäger, Helmut Friess, Julia Mayerle, Guido Adler, Thomas Seufferlein, Thomas Gress, Roland Schmid and Markus W Büchler |
| 246 | 3 | 0 | |a Alpha-zweib fünf-FU CapRI-zwei |
| 264 | 1 | |c 2009 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Märten, Angela |d 1968- |0 (DE-588)122240103 |0 (DE-627)081822456 |0 (DE-576)293167931 |4 oth | |
| 700 | 1 | |a Schmidt, Jan |d 1961- |0 (DE-588)1022937995 |0 (DE-627)717335852 |0 (DE-576)366198017 |4 oth | |
| 700 | 1 | |a Ose, Jennifer |d 1979- |0 (DE-588)1136678018 |0 (DE-627)893435805 |0 (DE-576)490759270 |4 oth | |
| 700 | 1 | |a Harig, Sabine |d 1967- |0 (DE-588)120041790 |0 (DE-627)696326973 |0 (DE-576)29200978X |4 oth | |
| 700 | 1 | |a Abel, Ulrich |d 1952- |0 (DE-588)14287552X |0 (DE-627)640555403 |0 (DE-576)333774582 |4 oth | |
| 700 | 1 | |a Münter, Marc |d 1972- |0 (DE-588)121295591 |0 (DE-627)705363104 |0 (DE-576)292633645 |4 oth | |
| 700 | 1 | |a Jäger, Dirk |d 1964- |0 (DE-588)1032507535 |0 (DE-627)738505323 |0 (DE-576)380074125 |4 oth | |
| 700 | 1 | |a Friess, Helmut |0 (DE-588)142541028 |0 (DE-627)637289676 |0 (DE-576)331508877 |4 oth | |
| 700 | 1 | |a Mayerle, Julia |d 1973- |0 (DE-588)124858643 |0 (DE-627)654711313 |0 (DE-576)339016078 |4 oth | |
| 700 | 1 | |a Adler, Guido |d 1946- |0 (DE-588)118187627 |0 (DE-627)079294553 |0 (DE-576)160029546 |4 oth | |
| 700 | 1 | |a Seufferlein, Thomas |d 1963- |0 (DE-588)1100314660 |0 (DE-627)859268187 |0 (DE-576)469593067 |4 oth | |
| 700 | 1 | |a Greß, Thomas |0 (DE-588)1141408821 |0 (DE-627)1000313522 |0 (DE-576)49438929X |4 oth | |
| 700 | 1 | |a Schmid, Roland |d 1960- |0 (DE-588)131498312 |0 (DE-627)707647428 |0 (DE-576)298547384 |4 oth | |
| 700 | 1 | |a Büchler, Markus W. |d 1955- |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 oth | |
| 773 | 0 | 8 | |i In |t BMC cancer |d London : BioMed Central, 2001 |g 9(2009) Artikel-Nummer 160, 8 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2 |
| 773 | 1 | 8 | |g volume:9 |g year:2009 |g extent:8 |a A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2407-9-160 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.biomedcentral.com/1471-2407/9/160 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210104 | ||
| 993 | |a Article | ||
| 994 | |a 2009 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 14 |y j | ||
| 998 | |g 118187627 |a Adler, Guido |m 118187627:Adler, Guido |p 10 | ||
| 998 | |g 1032507535 |a Jäger, Dirk |m 1032507535:Jäger, Dirk |d 910000 |e 910000PJ1032507535 |k 0/910000/ |p 7 | ||
| 998 | |g 121295591 |a Münter, Marc |m 121295591:Münter, Marc |d 50000 |e 50000PM121295591 |k 0/50000/ |p 6 | ||
| 998 | |g 14287552X |a Abel, Ulrich |m 14287552X:Abel, Ulrich |d 50000 |d 910000 |d 999701 |e 50000PA14287552X |e 910000PA14287552X |e 999701PA14287552X |k 0/50000/ |k 0/910000/ |k 1/910000/999701/ |p 5 | ||
| 998 | |g 120041790 |a Harig, Sabine |m 120041790:Harig, Sabine |p 4 | ||
| 998 | |g 1136678018 |a Ose, Jennifer |m 1136678018:Ose, Jennifer |d 50000 |e 50000PO1136678018 |k 0/50000/ |p 3 | ||
| 998 | |g 1022937995 |a Schmidt, Jan |m 1022937995:Schmidt, Jan |d 910000 |d 910200 |e 910000PS1022937995 |e 910200PS1022937995 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 998 | |g 122240103 |a Märten, Angela |m 122240103:Märten, Angela |d 50000 |e 50000PM122240103 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN622631748 |e 3829967691 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Angela Märten, Jan Schmidt, Jennifer Ose, Sabine Harig, Ulrich Abel, Marc W Münter, Dirk Jäger, Helmut Friess, Julia Mayerle, Guido Adler, Thomas Seufferlein, Thomas Gress, Roland Schmid and Markus W Büchler"]},"person":[{"family":"Märten","role":"oth","given":"Angela","display":"Märten, Angela"},{"family":"Schmidt","role":"oth","display":"Schmidt, Jan","given":"Jan"},{"given":"Jennifer","display":"Ose, Jennifer","family":"Ose","role":"oth"},{"given":"Sabine","display":"Harig, Sabine","family":"Harig","role":"oth"},{"given":"Ulrich","display":"Abel, Ulrich","role":"oth","family":"Abel"},{"family":"Münter","role":"oth","display":"Münter, Marc","given":"Marc"},{"family":"Jäger","role":"oth","given":"Dirk","display":"Jäger, Dirk"},{"given":"Helmut","display":"Friess, Helmut","role":"oth","family":"Friess"},{"given":"Julia","display":"Mayerle, Julia","family":"Mayerle","role":"oth"},{"display":"Adler, Guido","given":"Guido","family":"Adler","role":"oth"},{"role":"oth","family":"Seufferlein","given":"Thomas","display":"Seufferlein, Thomas"},{"family":"Greß","role":"oth","display":"Greß, Thomas","given":"Thomas"},{"display":"Schmid, Roland","given":"Roland","family":"Schmid","role":"oth"},{"given":"Markus W.","display":"Büchler, Markus W.","role":"oth","family":"Büchler"}],"recId":"622631748","physDesc":[{"extent":"8 S."}],"id":{"doi":["10.1186/1471-2407-9-160"],"eki":["622631748"]},"title":[{"title_sort":"randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2","title":"A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2009","dateIssuedKey":"2009"}],"relHost":[{"pubHistory":["1.2001 -"],"note":["Gesehen am 22.05.20"],"language":["eng"],"part":{"text":"9(2009) Artikel-Nummer 160, 8 Seiten","extent":"8","volume":"9","year":"2009"},"disp":"A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2BMC cancer","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"326643710","origin":[{"dateIssuedDisp":"2001-","publisher":"BioMed Central ; Springer","publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedKey":"2001"}],"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"id":{"eki":["326643710"],"issn":["1471-2407"],"zdb":["2041352-X"]},"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a RANDOMIZED2009 | ||